1887
  1. Home
  2. Eurosurveillance
  3. Volume 22, Issue 3, 19/Jan/2017
  4. Article
Surveillance and outbreak report Open Access
Like 0
Download

Abstract

Since the early 1990s, the Netherlands has experienced several large measles epidemics, in 1992–94, 1999–2000 and in 2013–14. These outbreaks mainly affected orthodox Protestants, a geographically clustered population with overall lower measles-mumps-rubella first dose (MMR-1) vaccination coverage (60%) than the rest of the country (> 95%). In the 2013–14 epidemic described here, which occurred between 27 May 2013 and 12 March 2014, 2,700 cases were reported. Several control measures were implemented including MMR vaccination for 6–14-month-olds and recommendations to reduce the risk in healthcare workers. The vast majority of reported cases were unvaccinated (94%, n = 2,539), mostly for religious reasons (84%, n = 2,135). The median age in the epidemic was 10 years, 4 years older than in the previous epidemic in 1999–2000. A likely explanation is that the inter-epidemic interval before the 2013–2014 epidemic was longer than the interval before the 1999–2000 epidemic. The size of the unvaccinated orthodox Protestant community is insufficient to allow endemic transmission of measles in the Netherlands. However, large epidemics are expected in the future, which is likely to interfere with measles elimination in the Netherlands and elsewhere.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.3.30443
2017-01-19
2024-11-18
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.3.30443
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/3/eurosurv-22-30443-3.html?itemId=/content/10.2807/1560-7917.ES.2017.22.3.30443&mimeType=html&fmt=ahah

References

  1. Griffin DE, Lin WH, Pan CH. Measles virus, immune control, and persistence. FEMS Microbiol Rev. 2012;36(3):649-62.  https://doi.org/10.1111/j.1574-6976.2012.00330.x  PMID: 22316382 
  2. Perry RT, Murray JS, Gacic-Dobo M, Dabbagh A, Mulders MN, Strebel PM, et al. Progress toward regional measles elimination - worldwide, 2000-2014. MMWR Morb Mortal Wkly Rep. 2015;64(44):1246-51.  https://doi.org/10.15585/mmwr.6444a4  PMID: 26562349 
  3. Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol. 2009;38(1):192-205.  https://doi.org/10.1093/ije/dyn224  PMID: 19188207 
  4. van Lier EA, Oomen PJ, Giesbers H, Conyn-van Spaendonck MAE, Drijfhout IH, Zonnenberg-Hoff IF, et al. Vaccinatiegraad Rijksvaccinatieprogramma Nederland: verslagjaar 2014. [Immunisation coverage National Immunisation Programme in the Netherlands; Year of report 2014]. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu. 13 Jun 2014. Dutch. Available from: http://www.rivm.nl/dsresource?objectid=7990c7ad-415f-4e3b-8068-dd67b6ed3b7d&type=org&disposition=inline
  5. van der Zwan CW, Plantinga AD, Rümke HC, Conyn-van Spaendonck MA. [Measles in The Netherlands; epidemiology and the effect of vaccination]. Ned Tijdschr Geneeskd. 1994;138(48):2390-5. PMID: 7990986 
  6. van den Hof S, Conyn-van Spaendonck MA, van Steenbergen JE. Measles epidemic in the Netherlands, 1999-2000. J Infect Dis. 2002;186(10):1483-6.  https://doi.org/10.1086/344894  PMID: 12404165 
  7. World Health Organization (WHO). Global eradication of measles: report by the Secretariat. Geneva: WHO; 2010. [Accessed 15 Sep 2015]. Available from: http://apps.who.int/gb/ebwha/pdf_files/wha63/a63_18-en.pdf
  8. Hahné S, te Wierik MJ, Mollema L, van Velzen E, de Coster E, Swaan C, et al. Measles outbreak, the Netherlands, 2008. Emerg Infect Dis. 2010;16(3):567-9.  https://doi.org/10.3201/eid1602.090114  PMID: 20202450 
  9. Ruijs WL, Hautvast JL, van der Velden K, de Vos S, Knippenberg H, Hulscher ME. Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study. BMC Public Health. 2011;11(1):102.  https://doi.org/10.1186/1471-2458-11-102  PMID: 21320348 
  10. Ruijs WL, Hautvast JL, van Ansem WJ, Akkermans RP, van’t Spijker K, Hulscher ME, et al. Measuring vaccination coverage in a hard to reach minority. Eur J Public Health. 2012;22(3):359-64.  https://doi.org/10.1093/eurpub/ckr081  PMID: 21715468 
  11. Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Overzicht gemeenten met lage vaccinatiegraad mazelen. [Overview municipalities with low vaccination coverage]. Bilthoven: RIVM. [Accessed 2 Sep 2015]. Dutch. Available from: http://www.rivm.nl/dsresource?objectid=cb19275c-90db-42cc-a60d-e60399fbdf64&type=org&disposition=inline
  12. Ruijs WL, Hautvast JL, Akkermans RP, Hulscher ME, van der Velden K. The role of schools in the spread of mumps among unvaccinated children: a retrospective cohort study. BMC Infect Dis. 2011;11(1):227.  https://doi.org/10.1186/1471-2334-11-227  PMID: 21864363 
  13. Mollema L, Smits GP, Berbers GA, Van Der Klis FR, Van Binnendijk RS, De Melker HE, et al. High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands. Epidemiol Infect. 2014;142(5):1100-8.  https://doi.org/10.1017/S0950268813001532  PMID: 23915981 
  14. Knol M, Urbanus A, Swart E, Mollema L, Ruijs W, van Binnendijk R, et al. Large ongoing measles outbreak in a religious community in the Netherlands since May 2013. Euro Surveill. 2013;18(36):20580.  https://doi.org/10.2807/1560-7917.ES2013.18.36.20580  PMID: 24079377 
  15. Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Advies bescherming tegen mazelen in de gezondheidszorg. [Advice - Protection against measles within health care]. Bilthoven: RIVM. [Accessed 15 Sep 2015]. Dutch. Available from: http://www.rivm.nl/dsresource?objectid=af82c413-721a-4258-9934-8a42f585a10f&type=org&disposition=inline
  16. Waaijenborg S, Hahné SJ, Mollema L, Smits GP, Berbers GA, van der Klis FR, et al. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208(1):10-6.  https://doi.org/10.1093/infdis/jit143  PMID: 23661802 
  17. Moss WJ, Griffin DE. Measles. Lancet. 2012;379(9811):153-64.  https://doi.org/10.1016/S0140-6736(10)62352-5  PMID: 21855993 
  18. Ruijs WL. Acceptance of Vaccination among orthodox Protestants in the Netherlands. Ipskamp Drukkers, Enschede: 2012. Available from: http:repository.ubn.ru.nl/bitstream/2066/98582/1/98582.pdf.
  19. European Centre for Disease Prevention and Control (ECDC). Measles case definitions. Stockholm: ECDC. [Accessed 15 Sep 2015]. Available from: http://ecdc.europa.eu/en/healthtopics/vaccine-preventable-diseases/euvac/case_definition/Pages/measles.aspx.
  20. Bankamp B, Byrd-Leotis LA, Lopareva EN, Woo GK, Liu C, Jee Y, et al. Improving molecular tools for global surveillance of measles virus. J Clin Virol. 2013;58(1):176-82.  https://doi.org/10.1016/j.jcv.2013.05.018  PMID: 23806666 
  21. Suijkerbuijk AW, Woudenberg T, Hahné SJ, Nic Lochlainn L, de Melker HE, Ruijs WL, et al. Economic Costs of Measles Outbreak in the Netherlands, 2013-2014. Emerg Infect Dis. 2015;21(11):2067-9.  https://doi.org/10.3201/eid2111.150410  PMID: 26488199 
  22. van den Hof S, Wallinga J, Widdowson MA, Conyn-van Spaendonck MA. Options for improvement of the Dutch measles vaccination schedule. Vaccine. 2003;21(7-8):721-4.  https://doi.org/10.1016/S0264-410X(02)00588-1  PMID: 12531348 
  23. Wallinga J, Teunis P, Kretzschmar M. Reconstruction of measles dynamics in a vaccinated population. Vaccine. 2003;21(19-20):2643-50.  https://doi.org/10.1016/S0264-410X(03)00051-3  PMID: 12744901 
  24. van Isterdael CE, van Essen GA, Kuyvenhoven MM, Hoes AW, Stalman WA, de Wit NJ. Measles incidence estimations based on the notification by general practitioners were suboptimal. J Clin Epidemiol. 2004;57(6):633-7.  https://doi.org/10.1016/j.jclinepi.2003.11.012  PMID: 15246133 
  25. Antona D, Lévy-Bruhl D, Baudon C, Freymuth F, Lamy M, Maine C, et al. Measles elimination efforts and 2008-2011 outbreak, France. Emerg Infect Dis. 2013;19(3):357-64.  https://doi.org/10.3201/eid1903.121360  PMID: 23618523 
  26. Richard JL, Masserey Spicher V. Large measles epidemic in Switzerland from 2006 to 2009: consequences for the elimination of measles in Europe. Euro Surveill. 2009;14(50):19443. PMID: 20070934 
  27. Wichmann O, Siedler A, Sagebiel D, Hellenbrand W, Santibanez S, Mankertz A, et al. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bull World Health Organ. 2009;87(2):108-15.  https://doi.org/10.2471/BLT.07.050187  PMID: 19274362 
  28. Hepp DH, van Dijk K, Stam CJ, van Oosten BW, Foncke EM. [Progressive cognitive disturbances in a 17-year-old boy]. Ned Tijdschr Geneeskd. 2015;159:A8490. PMID: 25761293 
  29. Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol. 2007;36(6):1334-48.  https://doi.org/10.1093/ije/dym207  PMID: 18037676 
  30. Fiebelkorn AP, Seward JF, Orenstein WA. A global perspective of vaccination of healthcare personnel against measles: systematic review. Vaccine. 2014;32(38):4823-39.  https://doi.org/10.1016/j.vaccine.2013.11.005  PMID: 24280280 
  31. Anderson RM, May RM. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J Hyg (Lond). 1985;94(3):365-436.  https://doi.org/10.1017/S002217240006160X  PMID: 4008922 
  32. Swart EM, van Gageldonk PGM, de Melker HE, van der Klis FR, Berbers GAM, Mollema L. Long-term protection against diphtheria in the Netherlands after 50 years of vaccination: results from a seroepidemiological study. PLoS One. 2016;11(2):e0148605.  https://doi.org/10.1371/journal.pone.0148605  PMID: 26863307 
  33. European Centre for Disease Prevention and Control (ECDC). Measles and rubella monitoring, February 2014 – Reporting on January – December 2013 surveillance data and epidemic intelligence data to the end of February 2014. Stockholm: ECDC. [Accessed 24 Oct 2015]. Available from: http://ecdc.europa.eu/en/publications/Publications/measles-rubella-monitoring-february-2014.pdf
  34. Public Health England (PHE). Measles Nucleotide Surveillance. London: PHE. [Accessed 15 Nov 2015]. Available from: http://www.who-measles.org/Public/Web_Front/main.php.
  35. De Schrijver K, Sansen M, Hutse V, Boeckx H, van den Branden D, Flipse W. Een mazelenuitbraak in een crèche in Zwijndrecht, april 2014. [A measles outbreak in a nursery in Zwijndrecht, April 2014]. [Accessed 17 Nov 2015]. Dutch. Available from: https://www.zorg-en-gezondheid.be/sites/default/files/atoms/files/Kort%20gerapporteerd%202014-5.pdf
  36. Kershaw T, Suttorp V, Simmonds K, St. Jean T. Outbreak of measles in a non-immunizing population, Alberta 2013. Can Commun Dis Rep. 2014;40(12):243-50.
  37. Naus M, Puddicombe D, Murti M, Fung C, Stam R, Loadman S, et al. Outbreak of measles in an unvaccinated population, British Columbia, 2014. Can Commun Dis Rep. 2015;41(7):169-74.
  38. Washington State Department of Health. Measles: Whatcom County case, potential public exposures in other counties. Washington State Department of Health. 2 Apr 2014. Available from: http://www.doh.wa.gov/Newsroom/2014NewsReleases/14047MeaslesMultiCounty
  39. Wielders CC, van Binnendijk RS, Snijders BE, Tipples GA, Cremer J, Fanoy E, et al. Mumps epidemic in orthodox religious low-vaccination communities in the Netherlands and Canada, 2007 to 2009. Euro Surveill. 2011;16(41):19989. PMID: 22008201 
  40. European Centre for Disease Prevention and Control (ECDC). National plans for measles and Rubella. Stockholm: ECDC. [Accessed 28 Sep 2016]. Available from: http://ecdc.europa.eu/en/healthtopics/vaccine-preventable-diseases/Pages/National-plans.aspx
  41. Ruijs WL, Hautvast JL, van Ijzendoorn G, van Ansem WJ, van der Velden K, Hulscher ME. How orthodox protestant parents decide on the vaccination of their children: a qualitative study. BMC Public Health. 2012;12(1):408.  https://doi.org/10.1186/1471-2458-12-408  PMID: 22672710 
  42. Nederlandse Patiëntenvereniging. Vaccinatie: voorzienigheid, vertrouwen en verantwoordelijkheid. [Vaccination: providence, trust and responsibility]. [Accessed 15 Sept 2016]. Dutch. Available from: http://npvzorg.nl/wp-content/uploads/2016/05/Brochure-ouders_spreads.compressed.pdf
Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Tom+Woudenberg&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Woudenberg Tom</a>, <a href="/search?value1=Rob+S.+van+Binnendijk&option1=author&noRedirect=true" class="nonDisambigAuthorLink">van Binnendijk Rob S.</a>, <a href="/search?value1=Elisabeth+A.+M.+Sanders&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sanders Elisabeth A. M.</a>, <a href="/search?value1=Jacco+Wallinga&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Wallinga Jacco</a>, <a href="/search?value1=Hester+E.+de+Melker&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Melker Hester E.</a>, <a href="/search?value1=Wilhelmina+L.+M.+Ruijs&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ruijs Wilhelmina L. M.</a>, <a href="/search?value1=Susan+J.+M.+Hahn%C3%A9&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hahné Susan J. M.</a></span>. Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology. <a href="/content/ecdc">Euro Surveill.</a> 2017;22(3):pii=30443. <a href="https://doi.org/10.2807/1560-7917.ES.2017.22.3.30443" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2017.22.3.30443</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 06 Jan 2016;&nbsp;&nbsp; <span class="generated">Accepted</span>: 21 Oct 2016 </span> </p>
/content/10.2807/1560-7917.ES.2017.22.3.30443
/content/10.2807/1560-7917.ES.2017.22.3.30443
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error